




This is the author’s final version of the work, as accepted for publication  
following peer review but without the publisher’s layout or pagination.  
The definitive version is available at: 
 
 




Lockwood, A., Currie, A., Hancock, S., Broomfield, S., Liu, S., 
 Scanlan, V., Kearney, G.A. and Thompson, A.N. (2016) 
Supplementation of Merino ewes with cholecalciferol in late  
 pregnancy improves the vitamin D status of ewes and lambs at 
 birth but is not correlated with an improvement in immune function 







Copyright: © CSIRO 2016. 
It is posted here for your personal use. No further distribution is permitted. 
 
 
Supplementation of Merino ewes with cholecalciferol in late 
pregnancy improves the vitamin D status of ewes and lambs at 
birth but is not correlated with an improvement in immune 
function in lambs 
 
A. Lockwood A , A. Currie A , S. Hancock A , S. Broomfield A , S. Liu B , V. Scanlan A , G. A. 
Kearney C and A. N. Thompson A 
 
A School of Veterinary and Life Sciences, Murdoch University, Murdoch, WA 6150, Australia. 
B School of Animal Biology, University of Western Australia, Crawley, WA 6009, Australia. 
C Hamilton, Vic. 3300, Australia. 
 
Abstract 
Functional deficiencies of the immune system are known to predispose human and animal neonates to 
death. Thus, immune competency may be a significant factor influencing the mortality of lambs. 
Vitamin D has been recognised to improve immune function and is transferred across the placenta. 
This study tested the hypotheses that (1) supplementation of Merino ewes with cholecalciferol during 
late pregnancy will increase the concentrations of vitamin D in the ewe and lamb at birth and (2) 
supplementation of Merino ewes with cholecalciferol during late pregnancy is correlated with an 
increase in innate phagocytic and adaptive antibody immune responses in the lamb. Merino ewes 
(n = 53) were injected intramuscularly with 1 × 106 IU cholecalciferol at Days 113 and 141 of 
pregnancy. A control group (n = 58) consisted of ewes receiving no additional nutritional treatments. 
The vitamin D status of ewes and lambs was assessed up until 1 month post-lambing. Lamb immune 
function was assessed by analysing the functional capacity of phagocytes, and the plasma IgG and 
anti-tetanus-toxoid antibody concentrations between birth and weaning. Maternal supplementation 
with cholecalciferol increased the plasma 25(OH)D concentrations of both ewes (137 vs 79 
nmol/L; P < 0.001) and lambs (49 vs 24 nmol/L; P < 0.001) at birth compared with the controls. 
Supplementation with cholecalciferol had no significant effect on the phagocytic capacity of 
monocytes or polymorphonuclear leukocytes, the concentration of IgG in the colostrum or plasma of 
lambs, or the vaccine-specific antibody response against tetanus toxoid. Overall, the results support 
our first hypothesis, but suggest that maternal supplementation with 1 × 106 IU cholecalciferol does 
not improve innate, passive or adaptive immune function in lambs. 
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Introduction 
Lamb mortality represents a major production loss for the Australian sheep industry. On average, 30% 
of all lambs born will die before weaning, and ~80% of lamb deaths occur in the first 48–72 h of life 
(Miller et al. 2010; Oldham et al. 2011; Hawken et al. 2012; Hinch and Brien 2014; Paganoni et al. 
2014). Lamb birthweight is the greatest contributor to lamb survival and is strongly influenced by ewe 
nutrition during pregnancy (Oldham et al. 2011; Paganoni et al. 2014). However, even at the optimal 
birthweight of 4.5–5.5 kg (Oldham et al. 2011; Hinch and Brien 2014), lamb survival to weaning 
rarely exceeds 90% for singles, 75% for multiples and 60% for triplets (Paganoni et al. 2014), 
suggesting that factors independent of birthweight must also influence lamb survival. Functional 
innate and adaptive immune deficiencies in neonatal mammals are known to predispose them to 
infections, and the associated inflammation may cause tissue damage and/or dysfunction and death, 
particularly in the perinatal period (Firth et al. 2005; Futata et al. 2012). However, the role of immune 
competency in the survival of lambs is poorly understood. The incidence of infection directly causing 
death in lambs during the prenatal and neonatal periods ranges from 0.2% to 30% (Hughes et al. 
1971; Dennis 1974; Dwyer 2008; Rad et al. 2011), and while active infections have been previously 
identified in lambs, primarily via postmortem examination, the abilities of lambs to mount immune 
responses in early life have not been widely investigated. 
Neonatal lambs are reliant on passive transfer of antibodies from the ewe’s colostrum for protection in 
early life, and failure of passive transfer of immunity is well recognised as a cause of postnatal 
infection and death in lambs during the first week of life (Gokce and Erdogan 2009; Gokce et al. 
2014). Immunoglobulin-G (IgG) is the predominant immunoglobulin found in ewe colostrum and 
measurement of serum IgG concentration in neonatal lambs can be used as an indicator of immune 
status (Bernadina et al. 1991; Hashemi et al. 2008). Passively acquired IgG molecules have several 
functions that promote neonatal innate immune responses, including activation of complement, 
prevention of microorganism attachment to mucosal membranes and the opsonisation of bacteria for 
phagocytosis and killing (Parkin and Cohen 2001). Phagocytosis is an essential innate immune 
defence, whereby phagocytes identify, engulf and destroy invading pathogens through an array of 
cellular mechanisms (Tosi 2005). Phagocytosis is also essential in linking innate to adaptive immune 
responses, by promoting the induction of T-cell responses and, hence, humoral immunity (Prosser et 
al. 2013). Impaired phagocytosis in the newborn can lead to inadequate control of pathogen 
replication, resulting in higher microbial loads and greater induction of pathogen-driven inflammatory 
responses in affected tissues and organs (Garvy 2004). Hence, poor adaptive immune competency in 
ewes, and poor passive immunity in the lamb, along with immature phagocyte function in newborns, 
may be associated with adverse infection outcomes in lambs, and, therefore, could contribute to lamb 
mortality. 
Vitamin D has been recognised to have several roles in the regulation of immune function and can 
enhance innate antimicrobial immune responses, while dampening excessive adaptive responses and 
inflammation to maintain self-tolerance and prevent auto-immunity (Lang et al. 2013). During 
pregnancy, vitamin D is thought to enhance innate anti-microbial and anti-inflammatory responses 
within the placenta and reproductive tissues, which may protect the fetus from intrauterine infection 
and subsequent inflammation (Grayson and Hewison 2011). Maternal transfer of vitamin D to the 
lamb may occur in utero, or, to a lesser degree, postnatally via intake of milk (Lapillonne 2010). 
Thus, any vitamin D deficiency in pregnant ewes could have negative impacts on the immune system 
of the ewe and/or lamb. Increasing the vitamin D concentrations in neonatal lambs at birth may confer 
a greater ability to control infection and/or limit infection-driven inflammation, and, thus, may 
contribute to improved lamb survival. Supplementation of ewes with vitamin D during pregnancy 
could provide an effective means to increase the concentrations of vitamin D in the ewe and her 
lamb/s in utero, thereby improving innate and/or adaptive immunity in the ewe, and innate and/or 
passive immunity in the lamb. The present study, therefore, tested the hypotheses that (1) 
supplementation of Merino ewes with cholecalciferol during late pregnancy will increase the 
concentrations of vitamin D in the ewe and lamb at birth and (2) supplementation of Merino ewes 
with cholecalciferol during late pregnancy is correlated with an increase in innate phagocytic and 
adaptive antibody immune responses in the lamb. 
 
Materials and methods 
All procedures described were performed according to the guidelines of the Australian Code of 
Practice for the Use of Animals for Scientific Purposes 2013 and received approval from the Murdoch 
University Animal Ethics Committee. 
Research site, animals and experimental design 
The research was performed at the University of Western Australia Future Farm near Pingelly in 
Western Australia (32°30ʹ23ʹʹS, 116°59ʹ31ʹʹE) between November 2013 and August 2014. Two 
hundred Merino ewes aged between 4 and 7 years were sourced from the ‘Maternal Efficiency Flock’ 
(Rosales Nieto et al. 2013). All ewes had full pedigree records. Ewes were artificially inseminated 
with semen from four Merino sires, and those identified to be pregnant were allocated into three 
replicates of each of the two treatment groups, namely, control or vitamin D supplementation during 
late pregnancy. The ewes were shorn in November 2013 before artificial insemination. Lambing 
occurred during late April–early May 2014 and lambs were weaned in early August 2014. 
Animal management and treatments 
Ewes were managed to achieve a body condition score greater than three for joining. Oestrus was 
synchronised in ewes via controlled internal drug releases (Eazi-Breed™ CIDR® Sheep and Goat 
Device, Zoetis, Sydney, NSW, Australia) that were inserted into the vagina of all ewes 14 days before 
artificial insemination and were withdrawn 48 h before artificial insemination. One day before 
artificial insemination, the ewes were weighed and body condition was scored (Jefferies 1961). Ewes 
were artificially inseminated laproscopically in November 2013. Semen from the four sires was 
allocated to the ewes according to their age and liveweight and condition score before insemination. 
The ewes were managed as a single flock and grazed the same paddocks until Day 113 of pregnancy. 
Ewes were pregnancy scanned via trans-abdominal ultrasonography on Day 55 of pregnancy to 
identify single- and twin-bearing ewes (Fowler and Wilkins 1984). After confirmation of pregnancy 
status, ewes were weighed and condition scored every 1–2 weeks and nutrition was managed 
accordingly, so as to achieve a body condition score of 2.5 at lambing. The ewes grazed paddocks 
with very low levels of dry annual pastures and, on average, were supplemented with 700 g/day of 
supplementary feed (52% lupins (13.9 MJ ME/kg DM and 31.2% CP), 31% oats (12.8 MJ ME/kg DM 
and 12.2% CP) and 17% oaten chaff (9.3 MJ ME/kg DM and 7.6% CP)) between pregnancy scanning 
and lambing. 
On Day 111 of pregnancy, ewes were administered a clostridial 6-in-1 booster vaccine (Glanvac® 6, 
Zoetis). Ewes were then allocated into three replicates for each of the two treatment groups, namely, 
control or vitamin D supplementation, according to ewe age, sire of the lamb, pregnancy status, and 
liveweight and condition score at insemination (n = 17–20 ewes per treatment per replicate). The 
control group (n = 58) consisted of ewes receiving no additional nutritional treatments. Ewes 
supplemented with vitamin D (n = 53) received an injection of cholecalciferol (vitamin D3; Bova 
Compounding, Sydney, NSW, Australia) at Days 113 and 141 of pregnancy. On each occasion, 1.0 × 
106 IU cholecalciferol, in oil, was injected intramuscularly into the hind-limb. Each replicate of the 
two treatments was combined after the first injection of cholecalciferol and the three flocks of 37 
control and vitamin D ewes grazed separate pre-lambing plots until Day 141 of pregnancy. At this 
time, the ewes within each replicate were reallocated to a lambing plot according to treatment group, 
pregnancy status and lamb sire into two smaller groups, so there were six groups of 18–19 control and 
vitamin D ewes for lambing. Ewes remained in these six lambing plots until ~1 week post-lambing, at 
which point all ewes and their lambs were joined together and run as a single flock until weaning. 
Animal measurements and sample collection 
Pretreatment blood samples were collected from a subgroup of vitamin D and control ewes (n = 40) 
on Day 111 of pregnancy for subsequent analysis of vitamin D concentrations. At lambing, between 
Days 143 and 153 of pregnancy, ewes were intensively monitored between 0400 hours and 12 
midnight each day, for ewe and lamb sampling to occur before the lamb suckled following birth. All 
blood samples were collected via jugular venipuncture into heparinised vacutainer tubes. Following 
the initial collection of blood samples from lambs, only those lambs that were bled at birth were bled 
at subsequent time points in the study. All blood samples collected for vitamin D analysis were 
transported on ice, whereas those collected for immunological analysis were stored at room 
temperature following collection and for transport. Following transport, samples collected for vitamin 
D analysis were centrifuged for 15 min at 2278g to isolate plasma, which was then stored at -20°C. 
For immunological analysis, whole blood was isolated from blood samples collected from lambs at 
birth. The remainder of the sample, and all other lamb blood samples for immunological analysis, 
were centrifuged for 10 min at 952g to isolate plasma, which was then stored at -80°C. 
At birth, all lambs were weighed, and their dam, sex and birth type were recorded (n = 154). Two 5 
mL blood samples were collected from all single-born lambs and from the first lamb born only for 
lambs born in litters, provided they had not already suckled (n = 91), and the blood glucose 
concentration of the sample was measured immediately using a glucometer (Accu-Chek® Go, Roche 
Diagnostics, Sydney, NSW, Australia). Rectal temperatures were taken from most lambs using a 
digital thermometer. At least 30 mL of colostrum and a 9 mL blood sample were collected from all 
ewes for immunological and vitamin D analyses, respectively. Colostrum was temporarily stored at 
4°C, before being aliquoted and stored at -80°C for subsequent immunological analysis. 
One-week post-birth (±3 days), 5 mL blood samples were collected from the lambs (n = 91) for 
immunological analysis. Lambs were weighed ~2-weeks post-birth. Four weeks post-birth (±1 week), 
9 mL blood samples were collected from the subgroup of control and vitamin D-supplemented ewes 
(n = 40) for vitamin D analysis, and two 5 mL blood samples were collected from the lambs for 
vitamin D (n = 40) and immunological (n = 69) analyses. At marking, ~4 weeks post-birth, lambs were 
weighed and received their primary vaccinations (Glanvac® 6, Eryvac®, Gudair®, and Scabigard®; 
Zoetis). Two weeks following administration of the primary vaccines (Week 6), lambs were weighed 
and 5 mL blood samples were collected from the lambs for immunological analysis (n = 69). Lambs 
were then weighed every 2–3 weeks until weaning at ~14-weeks of age. At weaning, a 5 mL blood 
sample was also collected for immunological analysis (n = 65) and the lambs were administered 
clostridial booster vaccines (Glanvac® 6, Zoetis Australia). 
Vitamin D concentration assay 
Plasma samples collected from ewes at Day 111 of pregnancy, before treatments commenced (n = 40), 
and from both ewes and lambs at lambing (n = 80) and 4 weeks post-birth (n = 80), were analysed for 
concentrations of 25-hydroxyvitamin D using liquid chromatography tandem mass spectrometry (LC–
MS/MS) with electrospray ionisation in positive mode (ESI+). Colostrum samples (n = 40) collected 
from ewes at lambing and milk samples (n = 40) collected from ewes 4 weeks post-lambing were also 
analysed for 25-hydroxyvitamin D concentrations. Briefly, the internal standards d6-25-
hydroxyvitamin D2 and d6-25-hydroxyvitamin D3 were added into samples and, then, the sample was 
extracted using acetonitrile to release vitamin D from vitamin D-binding protein and precipitate 
proteins. Extracts were then chromatographed to further isolate vitamin D from potentially interfering 
substances and to separate the different forms of vitamin D (25-hydroxyvitamin D2 (25(OH)D2), 25-
hydroxyvitamin D3 (25(OH)D3) and C-3 epimer of 25-hydroxyvitamin D3 (C3-epi-25(OH)D3)). The 
various forms of vitamin D were quantified in a mass spectrometer (Waters Micromass Quattro 
Premier XE) with selected ion mode. While C3-epi-25(OH)D3 is not currently known to have any 
functionally active roles in the body and is not widely included in the measure of vitamin D status, a 
significant amount of C3-epi-25(OH)D3 was detected in the plasma samples in the present study. 
Thus, the total 25-hydroxyvitamin D (25(OH)D) concentrations in the present paper are presented as 
the total of 25(OH)D3 and 25(OH)D2, either excluding or including C3-epi-25(OH)D3. 
Whole blood differential cell counts 
Whole blood samples collected from lambs at birth and 4 weeks of age were analysed within 24 h for 
routine white blood cell differentials by using the Advia®120 automated hematology analyzer 
(Sequence 284; Siemens, Munich, Germany) in a high-output pathology laboratory (Clinical 
Pathology, Murdoch University Veterinary Hospital, Perth, WA, Australia). Briefly, the Advia 
machine adds peroxidase reagents to the samples to achieve erythrocyte lysis and fixation and staining 
of white blood cells. Monocytes and neutrophils are identified on the basis of light scatter and 
absorption data generated through analysis of samples in a peroxidase flow cytometry channel. 
Monocyte and neutrophil cell counts are displayed as a percentage of white blood cells. Manual 
counts by blood-smear microscopy were conducted where necessary, such as in the presence of blood 
clots or to confirm Advia data. 
Whole blood phagocytosis uptake assay 
Whole blood samples collected from lambs at birth and 4 weeks of age were analysed for monocyte 
and polymorphonuclear leukocyte phagocytic capacities using flow cytometry. pHrodo™ 
Red Staphylococcus aureus bioparticles® (Life Technologies, Carlsbad, CA, USA) were resuspended 
at 1 mg/mL in phosphate-buffered solution (PBS). Resuspended bioparticles were vortexed and 
sonicated to remove aggregates, before adding 40 µL to wells of a 96-well polypropylene plate. 
HEPES-buffered RMPI media supplemented with 5% heat-inactivated fetal calf serum was then 
added. Whole blood (25 µL) was added to the wells in duplicate, such that each blood sample was 
analysed with and without pHrodo™ bioparticles. Plates were incubated for 60 min at 37°C with 5% 
CO2 before transferring to ice. All samples were then stained with Brilliant Violet 421™ anti-human 
CD14 antibody (cross-reactive with sheep CD14), clone M5E2 (BioLegend, San Diego, CA, USA) 
for 15 min in the absence of light, for the identification of monocytes. Ice-cold PBS (100 µL) was 
added to each well before transfer of samples to FACS tubes containing 2 mL of ice-cold PBS. Tubes 
were centrifuged at 134g for 5 min at 10°C, before aspirating the supernatant and washing the cells 
with 1 mL of ice-cold PBS. Cells were pelleted and red blood cells lysed with 1 mL BD FACS™ 
Lysing Solution (BD Biosciences, San Jose, CA, USA) for 15 min at room temperature in the dark. 
Cells were then washed with 1 mL PBS before centrifuging and aspirating the supernatant. Cells were 
fixed by the addition of 200 µL of Stabilising Fixative (BD Biosciences). Samples were stored at 4°C 
in the dark before analysis by flow cytometry. 
Stained cells were analysed with a FACSCanto™ II cell analyser (BD Biosciences), alongside single 
stained compensation control beads (BD) for AlexaFluor405-anti-CD14 and pHrodo labelled cells. 
Detection of AF405 fluorescence was using a 530/30 nm band-pass filter, while pHrodo fluorescence 
was detected through a 670 nm long-pass filter. Equivalent fluorescence intensities for the instrument 
across the study were established using SPHERO Rainbow calibration beads (SpheroTech Inc., Lake 
Forest, IL, USA) and checked weekly. 
An inclusion gate for leukocytes was first identified on the basis of side- and forward-scatter 
properties and any debris was excluded. Singlet cells were identified from this inclusion gate by 
gating on side-scatter height and width. Phagocytes (high side scatter) and lymphocytes (low side 
scatter) were then identified, and the neutrophil and monocyte subpopulations were established on the 
basis of the absence or presence of CD14 staining. Histograms of pHrodo fluorescence were to 
determine the percentage of phagocytic neutrophils and monocytes and the median fluorescence 
intensity of positive cells recorded. Untreated whole blood samples served to determine the cut-off for 
pHrodo fluorescence and >5000 cells were collected from each sample. All flow-cytometry analyses 
were performed with applied compensation using Flowjo 10 software (TreeStar, Ashland, OR, USA). 
Total IgG assay 
Ewe colostrum samples, and plasma isolated from blood samples collected from lambs at 1, 4, 6 and 
14 weeks of age were analysed for total IgG concentrations using a single radial immunodiffusion 
assay for the detection of IgG, according to the manufacturer’s guidelines (IDRing® SheepandGoat 
IgG assay, IDBiotech, Issoire, France). The immunodiffusion precipitate rings were read using the 
IDRing® Viewer S120 (IDBiotech) and the total IgG concentration of each sample was calculated 
against a known standard (supplied), using the calculation spreadsheet provided by IDBiotech. 
Anti-tetanus-toxoid antibody assay 
The antibody assay described by (Adams et al. 1997) was optimised for use with ovine plasma 
samples. High-binding 96-well ELISA plates were coated with tetanus toxoid by adding 100 µL (final 
volume) of 619 Lf/mL highly purified tetanus toxin from Clostridium tetani (tetanus toxoid for in 
vitro tests, Statens Serum Institut, Copenhagen, Denmark) diluted to 1 : 1200 by using 0.05 M 
bicarbonate buffer + 1% bovine serum albumin (BSA) to each well. Plates were incubated overnight 
(16 h) at 4°C, before washing with Tris-buffered solution (TBS, pH 7.2) + 0.05% tween (TBS 
Tween®-20 Buffer, Thermo Scientific, Melbourne, Vic., Australia). Plates were filled with TBS + 
0.05% tween and incubated for 3 min at room temperature. The plates were then rinsed three times, 
refilled and incubated at room temperature for 3 min. The wash procedure was then repeated before 
emptying the plate. To prevent non-specific binding, plates were blocked by adding 100 µL of TBS + 
1% BSA to each well, and incubating at 4°C for 1 h. Plates were washed before adding 100 µL of 
plasma diluted 1 : 20 by using TBS + 0.05% tween + 1% BSA to each well. Plates were incubated for 
2 h at 37°C in humid conditions, to allow antibody–antigen binding. Following incubation, plates 
were washed to remove unbound antibody. Antibody binding was detected with 100 µL of developing 
antibody (HRP-Rabbit Anti-Sheep IgG, Invitrogen™, Camarillo, CA, USA) diluted 1 : 6000 by using 
TBS + 0.05% tween + 1% BSA and plates were incubated for 2 h at 37°C in humid conditions. Plates 
were washed before adding 100 µL of TMB substrate (1-Step™ Ultra TMB-ELISA, Thermo 
Scientific) to each well and incubating the plates at room temperature in the dark for 30 min. The 
reaction was terminated by adding 50 µL of 2 M sulfuric acid to each well. The absorbance of each 
sample was determined by reading the plate at 450 nm in a spectrophotometer (iMark™ Microplate 
Reader, Bio-Rad, Hercules, CA, USA). 
Statistical analyses 
All statistical analyses were performed using GENSTAT for Windows (15th edition; VSN 
International 2012, Hemel Hempstead, UK). For all analyses, interaction terms were included only if 
they were statistically significant (P < 0.05). Analysis also included, where appropriate, data from an 
additional 148 lambs that were concurrently studied to examine the effects of supplementation of the 
ewe with vitamin E or methionine during late pregnancy on similar parameters to those that are 
reported in the present paper. Where significant treatment effects were observed, the results presented 
include only data from vitamin D and control lambs. Where no treatment effects were observed, 
results presented for effects of gestational length, birthweight, birth type, sex and sire of the lamb 
include lambs from both control and vitamin D treatments and the additional lambs concurrently 
studied. 
Liveweights of ewes during pregnancy were corrected for weight of the conceptus by using the 
formula from the Grazfeed model (Freer et al. 1997), where Day 0 of pregnancy was the day of 
artificial insemination. Ewe liveweights corrected for the weight of the conceptus and ewe body 
condition scores were assessed using restricted maximum likelihood (REML) with a heterogenous 
power model in which the correlation between observations from the same animal decays as the time 
delay between the observations increases, along with allowing the variances at each time to be 
different so as to model repeated-measurements over time. For analysis of ewe liveweights and 
condition scores, treatment, pregnancy status (single- or multiple-bearing), date and interactions 
thereof were fitted as fixed effects and pre-lambing plot, stud from which the ewe was sourced (ewe 
source), sire of the ewe and ewe birth year were fitted as random effects. For pregnancy status of the 
ewe, multiple-bearing refers to both twin- and triple-bearing ewes. Lamb liveweights were also 
assessed by REML with treatment, sire of the lamb, birth type (single- or multiple-born) and sex fitted 
as fixed effects and pre-lambing plot, lambing plot (nested with pre-lambing plot), dam source, dam 
identification, sire of the dam and dam birth year fitted as random effects. For birth type of the lamb, 
multiple-born refers to both twin- and triple-born lambs. 
Ewe and lamb plasma vitamin D metabolite concentrations (total 25(OH)D excluding or including 3-
epi-25(OH)D3, 25(OH)D3, 3-epi-25(OH)D3 and 25(OH)D2) were assessed using REML. Where 
appropriate, the data were log-transformed. For analyses of data from ewes, treatment was fitted as a 
fixed effect and pre-lambing plot, ewe source, sire of the ewe and ewe birth year were fitted as 
random effects. In addition, for analyses of ewe data at lambing and 4 weeks after lambing, the 
respective vitamin D metabolite concentration (total 25(OH)D excluding or including the C3-epimer, 
25(OH)D3, 3-epi-25(OH)D3 or 25(OH)D2) before treatment was fitted as a covariate. For analyses of 
lamb data, treatment, sire of the lamb, birth type and sex, and interactions thereof, where appropriate, 
were fitted as fixed effects, and pre-lambing plot, lambing plot (nested within pre-lambing plot), dam 
source, sire of the dam and dam birth year were fitted as random effects. Analysis of the relationship 
between ewe total 25(OH)D at lambing and lamb total 25(OH)D at birth was assessed using REML 
with treatment, sire of the lamb, birth type and sex, and interactions thereof, where appropriate, fitted 
as fixed effects, and pre-lambing plot, lambing plot (nested within pre-lambing plot), dam source, sire 
of the dam, dam birth year and birth date of lamb were fitted as random effects. For this model, fixed 
terms were removed if not significant (P ≥ 0.05). 
Lamb immune-function parameters of monocyte and neutrophil cell counts and monocyte and 
polymorphonuclear leukocyte (PMNL) phagocytic capacities were assessed using REML. For 
analyses at 4 weeks of age, the respective cell count or phagocytic capacity at birth was fitted as a 
covariate. Plasma IgG concentrations and anti-tetanus-toxoid antibody absorbances were modelled 
over time using REML with a power model in which the correlation between observations from the 
same animal decays as the time delay between observations increases. Where necessary, the 
aforementioned data were angular- or log-transformed. For these analyses, treatment, sire of the lamb, 
gestational length, birthweight, birth type and sex, and interactions thereof, where appropriate, were 
fitted as fixed effects and pre-lambing plot and lambing plot (nested within pre-lambing plot), dam 
source, dam identification, sire of the dam, dam birth year and laboratory batch information, where 
appropriate, were fitted as random effects. 
Rectal temperatures and blood glucose concentrations of the lambs at birth were assessed using 
REML. Due to very strong leverage, five lambs that had rectal temperatures of <30°C, and 
subsequently died, were removed from the analysis. Blood glucose concentrations were log-
transformed. Treatment, sire of the lamb, birthweight, birth type, sex and interactions thereof, where 
appropriate, were fitted as fixed effects and pre-lambing plot, lambing plot (nested within pre-lambing 
plot), dam source, dam identification, sire of the dam and dam birth year were fitted as random 
effects. 
Lamb survival at birth, to 72 h and to weaning was assessed by fitting generalised linear mixed 
models. The approach used a logit-transformation and binomial distribution. Using additive models, 
logits were predicted as a function of the variables fitted as fixed and random effects. Treatment, 
birthweight, birthweight2, birth type, sex and sire of the lamb were fitted as fixed effects and lamb 
date of birth, pre-lambing plot, lambing plot (nested within pre-lambing plot), dam source, dam 
identification, sire of the dam and dam birth year were fitted as random effects. So as to assess the 
effects of the monocyte and neutrophil cell counts and monocyte and PMNL phagocytic capacities at 
birth on the survival of lambs to weaning, the respective immune measure was fitted as a covariate in 
the survival to weaning analyses. 
 
Results 
Ewe liveweights and body condition scores 
There was no significant difference in the mean liveweights of control and vitamin D ewes at artificial 
insemination (64.2 kg vs 63.8 kg), before treatments (Day 111 pregnancy; 63.2 kg vs 62.5 kg), before 
lambing (Day 141 pregnancy; 64.7 kg vs 65.0 kg), at lamb marking (57.9 kg vs 57.4 kg) or at lamb 
weaning (55.9 kg vs 55.5 kg). The mean body condition scores of control and vitamin D ewes also did 
not differ significantly at insemination (3.39 vs 3.38), before treatments (Day 111 of pregnancy; 2.37 
vs 2.38), before lambing (Day 141 of pregnancy; 2.59 vs 2.64), at lamb marking (2.61 vs 2.66) or at 
lamb weaning (2.77 vs 2.76). 
Gestational length, birthweight and lamb survival 
The mean gestational length of control and vitamin D ewes (148.5 vs 148.8 days) did not differ 
significantly and there were no significant differences in the gestational lengths of single- or multiple-
bearing ewes (150.1 vs 149.0 days). There was no significant difference between control and vitamin 
D lambs for birthweight, rectal temperature or blood glucose concentration at birth (Table 1). Male 
lambs were heavier than female lambs (4.62 vs 4.35 kg; P < 0.01), and single-born lambs were 
heavier than multiple-born lambs at birth (4.99 vs 3.97 kg; P < 0.001). Birthweight had no significant 
effect on the blood glucose concentrations of lambs; however, it had a significant positive effect on 
the rectal temperatures of lambs at birth (+0.5 ± 0.13°C/kg birthweight; P < 0.001). There was no 
significant effect of birth type or sex of the lamb on rectal temperature or blood glucose concentration 
at birth. 
Maternal supplementation with cholecalciferol had no significant effect on the survival of lambs 
(Table 1), or the growth of lambs to weaning. The survival of single-born lambs to weaning was 
significantly greater than that of multiple-born lambs (88.3% vs 68.5%; P < 0.001). Mean liveweights 
of vitamin D and control lambs at marking (Week 4) were 11.8 kg and 12.3 kg, respectively, and at 
weaning (Week 14) were 21.6 kg and 22.3 kg, respectively. Single-born lambs were consistently 
heavier than multiple-born lambs between birth and weaning (P < 0.001). There was no significant 
difference in the survival or growth of male and female lambs to weaning. 
Vitamin D concentrations in plasma, colostrum and milk 
The total 25(OH)D concentrations in plasma of control and vitamin D ewes did not differ significantly 
before supplementation (Table 2). Plasma total 25(OH)D concentrations, both including and 
excluding C3-epi-25(OH)D3, were significantly higher in vitamin D ewes than in control ewes at 
lambing and 4 weeks after lambing (Table 2). 
In comparison to the control lambs, the total 25(OH)D concentrations in plasma of lambs born to 
vitamin D-supplemented ewes were 65.6 nmol/L and 24.8 nmol/L higher at birth, with and without 
the inclusion of C3-epi-25(OH)D3, respectively. Both with or without the inclusion of C3-epi-
25(OH)D3, the plasma total 25(OH)D concentrations of vitamin D and control lambs did not differ 
significantly at 4 weeks of age (Table 2). Increased plasma total 25(OH)D concentrations in vitamin 
D-supplemented ewes at lambing and 4 weeks after lambing, and in their lambs at birth, were 
associated with a significant increase in the concentration of 25(OH)D3and not 25(OH)D2, compared 
with the controls (P < 0.001). 
There was a significant (P < 0.001) positive correlation between the total 25(OH)D (excluding C3-
epi-25(OH)D3) concentrations in the plasma of ewes at lambing and their lambs at birth (Fig. 1). With 
the exclusion of C3-epi-25(OH)D3, birth type and sex had no significant effect on the total 
concentrations of 25(OH)D in the plasma of lambs at birth; however, with the inclusion of C3-epi-
25(OH)D3, the total 25(OH)D concentrations were significantly higher in the plasma of multiple-born 
lambs than in that of the single-born lambs (110.3 vs 84.6 nmol/L; P < 0.001) and in the male lambs 
than in the female lambs (106.3 vs 87.8 nmol/L; P < 0.001). At 4 weeks of age, birth type and sex had 
no significant effect on the total concentrations of 25(OH)D in the plasma of lambs. 
Using the method employed in the present study, the concentration of 25(OH)D3 in colostrum was 
detectable only in 10 samples (2–6 nmol/L), while the concentration of 25(OH)D2 was detectable only 
in five samples (1–10 nmol/L). The concentrations of 25(OH)D3 and 25(OH)D2 in milk samples 
collected 4-weeks after lambing were all below the level of detection. 
Leukocyte counts and phagocytic capacities 
There were no significant differences between lambs from control and vitamin D-supplemented ewes 
in the percentages of circulating monocytes (2.9% vs 3.0%) or neutrophils (55.3 vs 47.0%) in whole 
blood at birth. At 4 weeks of age, there were no significant differences in the percentages of 
monocytes or neutrophils in the whole blood of control (5.3% and 29.4%, respectively) and vitamin 
D-supplemented (5.6% and 28.7%, respectively) lambs. 
The percentage of phagocytic monocytes in whole blood of control lambs did not differ significantly 
from that of the vitamin D-supplemented lambs at birth (84.2% vs 85.0%) or 4 weeks of age (98.6% 
vs 98.2%). There were also no significant differences in the percentages of phagocytic 
polymorphonuclear leukocytes (PMNL) in the whole blood of control or vitamin D-supplemented 
lambs at birth (60.0% vs 60.2%) or 4 weeks of age (91.2% vs 92.8%). 
Gestational length, birthweight, birth type or sex of the lamb had no significant effect on the 
percentages of circulating monocytes or neutrophils or the percentages of phagocytic monocytes or 
PMNL at birth or 4 weeks of age. 
IgG concentrations of colostrum and lamb plasma 
There was no significant difference in the concentration of IgG in the colostrum between control and 
vitamin D-supplemented (80.4 vs 82.3 mg/mL) ewes, and there was no significant effect of pregnancy 
status on colostrum IgG concentration. Lambs were born agammaglobulinemic (0 mg IgG/mL) and 
plasma IgG concentrations of control and vitamin D lambs did not differ at 1, 4, 6 or 14 weeks of age 
(Fig. 2). The plasma IgG concentrations of lambs differed significantly (P < 0.001) between 
consecutive time-points of analysis, but there was no significant interaction with treatment. 
Single-born lambs had significantly (P < 0.001) higher plasma IgG concentrations at 1 week of age 
(18.3 mg/mL) than multiple-born lambs (15.6 mg/mL), but not at 4, 6 or 14 weeks of age. Male lambs 
had significantly (P < 0.01) higher plasma IgG concentrations than female lambs, but there was no 
interaction among plasma IgG concentrations, sex and the week of analysis. Gestational length and 
birthweight had no significant effect on the plasma IgG concentrations of lambs. 
Anti-tetanus-toxoid antibody concentrations 
The absorbances of plasma samples of control and vitamin D-supplemented lambs analysed for anti-
tetanus-toxoid antibodies did not differ at 1, 4, 6 or 14 weeks of age (Fig. 3). Between consecutive 
time-points of analysis, the absorbances of lamb plasma samples were significantly (P < 0.001) 
different, but there was no significant interaction with treatment. Plasma samples from single-born 
lambs (0.69 nm) had significantly (P < 0.01) higher absorbances than did those from multiple-born 
lambs at 1 week of age (0.57 nm), but not at 4, 6 or 14 weeks of age. There was no significant effect 
of gestational length, birthweight or sex on the absorbances of plasma samples at 1, 4, 6 or 14-weeks. 
Discussion 
Maternal supplementation with cholecalciferol in late pregnancy increased the plasma concentrations 
of 25(OH)D, excluding C3-epi-25(OH)D3, in supplemented ewes by 74%, at lambing, and this 
doubled the plasma 25(OH)D concentrations in their lambs at birth, supporting our first hypothesis. 
Supplementation of ewes with cholecalciferol in late pregnancy was not correlated with an increase in 
the percentage of phagocytic monocytes or PMNLs in lambs at birth or 4 weeks of age, or in the 
plasma concentrations of IgG or anti-tetanus-toxoid antibody of lambs between birth and weaning; 
thus, our second hypothesis was rejected. Overall, our findings suggested that supplementing ewes 
twice with 1 × 106 IU cholecalciferol during late pregnancy is not effective at boosting the immune 
competency of lambs during the neonatal period and, therefore, is unlikely to reduce lamb mortality. 
The plasma 25(OH)D3 concentrations of ewes and lambs in the present study are similar to those 
reported by Smith et al. (1987). In response to supplementation, the plasma 25(OH)D concentrations 
of the ewes continued to increase during the first month following lambing, whereas the plasma 
25(OH)D concentrations of lambs born both to supplemented and control ewes had declined by 4 
weeks of age. While the plasma half-life of cholecalciferol is only 4–6 h, cholecalciferol is stored in 
the adipose tissue, muscle and liver, and has a whole-body half-life of ~2 months (Jones 2008). Thus, 
the increase in the plasma 25(OH)D concentrations between lambing and 4 weeks post-lambing 
indicated that release of stored cholecalciferol continued to increase the plasma 25(OH)D 
concentrations of ewes for at least 2 months following the initial supplementation. 25-hydroxyvitamin 
D, which is the precursor for biologically active vitamin D (1,25-dihydroxyvitamin D), is the only 
vitamin D metabolite known to readily cross the placenta of humans and rodents (Lapillonne 
2010; Roth 2011; Thorne-Lyman and Fawzi 2012; Kovacs 2013), and consistent with our 
findings, Smith et al. (1987) found that ewe and lamb plasma 25(OH)D3 concentrations were 
positively correlated at birth. The half-life of 25(OH)D is 2–3 weeks (Jones 2008; Holick 
2009; Gezmish and Black 2013), and, therefore, 25(OH)D in the plasma of lambs at birth, acquired 
via placental transfer, would persist only for up to 2–3 weeks after birth. The decline in plasma 
25(OH)D concentrations during the first 4 weeks of life in lambs born to vitamin D-supplemented 
ewes also suggests that ewe colostrum and milk were a poor source of vitamin D for the lambs. This 
is consistent with the analytic results of 25(OH)D concentrations in colostrum and milk samples, 
which were below 10 nmol/L at lambing and 4 weeks after lambing. Very low concentrations of 
vitamin D metabolites are also found in human and bovine milk, which is understood to be due to the 
very low concentrations of vitamin D-binding protein in the milk (Hollis et al. 1981; Kovacs 2013). 
We, therefore, conclude that large intramuscular doses of cholecalciferol in late pregnancy could not 
significantly increase the concentrations of vitamin D in the plasma of lambs during early post-natal 
life due to a rapid decline in 25(OH)D acquired via placental transfer from the ewe, along with a very 
low rate of transport of maternal vitamin D into the milk and, thus, to the offspring via suckling. 
The minor improvement in the vitamin D status of lambs following supplementation of ewes with 
cholecalciferol in late pregnancy may also be associated with the efficacy of the route of 
supplementation and the vitamin D metabolite used to supplement the ewes. While intravenous or 
large oral doses of cholecalciferol in humans generate a more rapid response in plasma 25(OH)D 
concentrations, large intramuscular or subcutaneous doses of cholecalciferol in oil are able to provide 
a sustained source of 25(OH)D to increase plasma concentrations over time (Whyte et al. 1979). 
However, peak plasma 25(OH)D concentrations may not be reached until up to 2 months post-
supplementation when cholecalciferol is administered via intramuscular or subcutaneous injection, as 
seen in the present study, which may be associated with a reduced bioavailability of vitamin D when 
administered via these routes (Whyte et al. 1979; Vieth 1999). 25-hydroxyvitamin D3 is known to be 
more potent than, and has an increased bioavailability compared with cholecalciferol, and, thus, 
supplementation with 25-hydroxyvitamin D3 is recognised to be between 4.2 and 5 times more 
effective at improving the vitamin D status of an individual than supplementation with cholecalciferol 
(Cashman et al. 2012; Borel et al. 2015). Supplementing ewes with 25(OH)D3 during late pregnancy 
may therefore be more effective at boosting the vitamin D status of ewes and fetal lambs than 
supplementation with cholecalciferol. Furthermore, it is unknown whether ewes and lambs in the 
present study were in a state of vitamin D sufficiency; hence, the plasma 25(OH)D concentration 
thresholds for vitamin D deficiency, sufficiency and toxicity in young and adult sheep need to be 
defined. Further research is also required to determine the biological significance of C3-epi-
25(OH)D3 and whether it should be included when reporting the vitamin D status of the body. 
The ability of lamb monocytes and PMNLs to engulf S. aureus bioparticles was not influenced by 
maternal supplementation with cholecalciferol during late pregnancy. In contrast, Abu-Amer and Bar-
Shavit (1993) showed that the phagocytic capacity of macrophages was poorer in vitamin D-deficient 
mice compared with vitamin D-replete mice. Furthermore, nutritional supplementation of weanling 
pigs with cholecalciferol or 25(OH)D significantly increased the phagocytic capacity of blood 
monocytes and granulocytes (Konowalchuk et al. 2013). The percentages of phagocytic monocytes 
and PMNLs in the whole blood of lambs at birth were similar to those seen in the cord blood 
(Hallwirth et al. 2002) and peripheral blood (Prosser et al. 2013) of human infants, and, as expected, 
the ability of the lamb monocytes and PMNLs to engulf the bacterial bioparticles was higher at 4 
weeks of age than at birth, reflecting maturation of the lamb’s immune system (Menge et al. 1998). 
The use of S. aureus bioparticles to assess phagocytic uptake of bacteria in lambs appears to be an 
appropriate bacterial model based on the findings of Dennis (1974) and Hughes et al. (1971), who 
observed that S. aureuswas one of the major bacterial species infecting lambs and, furthermore, that 
this bacterium was associated with pneumonia, polyarthritis and peritonitis, which are recognised to 
be common causes of infection-related death in lambs (Mellor and Stafford 2004). However, the 
interactions between the plasma vitamin D concentrations of the lambs and the antimicrobial killing 
and inflammatory responses of lamb monocytes and PMNLs, including the production of reactive 
oxygen species, anti-microbial peptides and cytokines, should be investigated. 
Supplementation of ewes with cholecalciferol did not affect the concentrations of IgG in the 
colostrum or in the plasma of lambs at 1 week of age or following administration of primary vaccines. 
This indicates that supplementation did not influence the production of maternal antibodies in the 
colostrum or the passive immune status of lambs, and also had no effect on the adaptive antibody 
immune responses in the lambs. The colostral IgG concentrations of control and vitamin D-
supplemented ewes at lambing were within the range of 64.2–99.4 mg/mL reported by previous 
studies (Gilbert et al. 1988; al-Sabbagh et al. 1995; Loste et al. 2008; Swanson et al. 2008). The 
plasma concentrations of IgG in control and vitamin D-supplemented lambs at 1 and 4 weeks of age 
were slightly lower than those reported in other breeds of sheep (Yılmaz et al. 2011; Gokce et al. 
2014). However, the optimal plasma concentrations of IgG in lambs in early life have not been 
reported and, therefore, it is difficult to establish whether the lambs in the present study had an 
adequate passive immune status. 
Vaccination clearly boosted vaccine-specific anti-tetanus-toxoid antibody titers in lambs, but we did 
not observe any effect of maternal supplementation with cholecalciferol on the antibody immune 
response to tetanus toxoid. The absorbance values of the lamb plasma samples analysed for anti-
tetanus-toxoid antibodies in the present study were similar to those reported by Adams et al. 
(1997) who analysed anti-tetanus-toxoid antibody titers in adult ewes following administration of 
booster vaccines; however, to the best of our knowledge, our study is the first to measure the vaccine-
specific antibody response to tetanus toxoid in neonatal lambs. Although supplementation did not 
appear to influence the vaccine-specific response to tetanus toxoid in the lambs, it is possible that 
vaccine-specific antibody immune responses of the lambs to other vaccine antigens were affected by 
maternal supplementation with cholecalciferol. 
Maternal supplementation with cholecalciferol had no significant effect on the overall metabolic 
status of lambs at birth or on the growth or survival of lambs to weaning. Furthermore, the 
birthweights of the lambs were close to the range of 4.5–5.5 kg, at which maximum survival occurs, 
and the rectal temperatures and blood glucose concentrations at birth were similar to those reported 
previously, therefore indicating that the lambs were not at an increased risk of death in the first 72 h 
of life (Stafford et al. 2007; Miller et al. 2010; Chniter et al. 2013). On average, only 4.6% of lambs 
born alive died within the first 72 h of life in the present study, which is considerably lower than the 
expected mortality of 20–30% (Oldham et al. 2011; Hawken et al. 2012; Hinch and Brien 2014). We 
therefore expect that the limited number of lamb deaths during this high-risk period was due to the 
high level of intervention associated with intensive sampling at lambing. 
Overall, our novel findings showed that supplementation of ewes with two large intramuscular doses 
of 1 × 106 IU cholecalciferol in late pregnancy is unsuccessful in boosting the immune competency of 
the lamb during early life. Colostrum and milk are poor sources of vitamin D and, therefore, young 
lambs may require direct supplementation in the early neonatal period, in order to increase plasma 
vitamin D concentrations sufficiently high to generate a response in the immune system. Further 
research is, therefore, needed to determine the requirements for vitamin D in young lambs and, 
additionally, what levels of vitamin D are required to optimise immune function. Subsequent research 
could then determine which approach to vitamin D supplementation is most effective at safely 
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Table 1.  Mean weights, rectal temperatures and blood glucose concentrations at birth and 
survival at birth, to 72 h and to weaning for lambs born to control and vitamin D-supplemented 
(Vit. D) ewes 
The ewes were supplemented with cholecalciferol on Days 113 and 141 of pregnancy. Values are 






















Table 2.  Mean plasma total 25-hydroxyvitamin D concentrations (nmol/L) of control and 
vitamin D-supplemented (Vit. D) ewes before supplementation (Day 111 pregnancy), at lambing 
and 4 weeks after lambing, and of their lambs at birth and 4 weeks of age 
The ewes were supplemented with cholecalciferol on Days 113 and 141 of pregnancy. Values are 















Fig. 1.  Relationship between the total concentration of 25-hydroxyvitamin D (25(OH)D) in the 
plasma of control and vitamin D-supplemented ewes at lambing and their lambs at birth. The dashed 
lines represent the 95% confidence intervals. The fitted line and confidence intervals are presented in 
the back-transformed state. The dots represent the raw data for the plasma 25(OH)D concentrations of 

















Fig. 2.  Mean plasma total immunoglobulin-G concentrations (±least significant intervals) of control 
(black) and vitamin D (grey) lambs at birth and 1, 4, 6 and 14 weeks of age. The ewes were 




















Fig. 3.  Mean absorbances (±least significant intervals) of control (black) and vitamin D (grey) lamb 
plasma samples analysed for anti-tetanus-toxoid antibodies between birth and weaning. The ewes 
were supplemented with cholecalciferol on Days 113 and 141 of pregnancy. Values are presented in 
the back-transformed state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
